Muslim spend on pharmaceuticals increased 6.5% in 2021 to $100 billion and is expected to reach $129 billion by 2025.
The COVID-19 pandemic brought into stark reality the shortcomings and inequalities present in global healthcare provision, particularly obvious in the poorer Organisation of Islamic Cooperation (OIC) countries.
These regions were not only impacted by the pandemic, but also by delays in rolling out national inoculation campaigns for other endemic diseases. Wealthier OIC countries have attempted to fill the vacuum by donating millions of doses of COVID-19 vaccines and providing other support.
Continue reading
Free, in under 30 seconds
Join thousands of professionals reading Salaam Gateway — the Global Islamic Economy Gateway.
Joined by 12,000+ Islamic economy professionals
Create a free account
Already a member? Sign in
- 5 free articles every month
- Weekly Islamic-economy newsletter
- Save articles to read later
